788 reports of this reaction
2.9% of all KETOCONAZOLE CREAM, 2% reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for KETOCONAZOLE CREAM, 2%, manufactured by Encube Ethicals, Inc.. There are 788 FDA adverse event reports linking KETOCONAZOLE CREAM, 2% to FATIGUE. This represents approximately 2.9% of all 27,109 adverse event reports for this drug.
Patients taking KETOCONAZOLE CREAM, 2% who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for KETOCONAZOLE CREAM, 2%, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for KETOCONAZOLE CREAM, 2%:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 788 FDA reports for KETOCONAZOLE CREAM, 2%. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.9% of all adverse event reports for KETOCONAZOLE CREAM, 2%, making it one of the most commonly reported side effect.
If you experience fatigue while taking KETOCONAZOLE CREAM, 2%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.